Clinical Research

Evolocumab reduces risk of major cardiac events in diabetic patients
Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial.
Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
Late-breaking PCI data challenge the 'time is muscle' paradigm
Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.
Early SAVR in asymptomatic heart patients linked to long-term benefits
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.
New data point to LAAO as a safe alternative to long-term drug therapy
At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

Virtual reality able to measure thoracic ultrasound skill

Want to level up your ultrasound abilities? This test may actually improve them.

Stephanie Golab, MD, NYU Grossman School of Medicine, explains statistics on heart transplant outcomes in older adults

It may be time to revisit patient selection protocols for heart transplants

In a new video interview, Stephanie Golab, MD, examines the latest data on heart transplant outcomes in older adults.

Football linked to damage of white matter in brain, a marker of dementia

Researchers discovered potential brain damage in both college and professional players.

National Science Foundation issues $1M grant to eliminate imaging contrast with AI

Case Western Reserve University researchers hope to make the diagnosis of cancer safer and less expensive.

TAVR patients face a higher risk of stroke for up to 2 years

A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer.

Scientists developing an AI alternative to chemical-based imaging contrast agents

Case Western Reserve University recently scored a $1.125 million grant from the National Science Foundation to help fuel its work, with a focus on MRI.

Endocarditis after SAVR more likely with bovine valves

Researchers examined data from more than 21,000 patients treated from 1997 to 2018, publishing their findings in the Journal of the American Heart Association.

Mayo Clinic rings in the new year with two AI-powered cancer care initiatives

Two AI developers have announced new agreements with the academic medical center, both related to improving the delivery of oncology services.

Clinical Research

Evolocumab reduces risk of major cardiac events in diabetic patients

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Late-breaking PCI data challenge the 'time is muscle' paradigm

Early SAVR in asymptomatic heart patients linked to long-term benefits

New data point to LAAO as a safe alternative to long-term drug therapy

Evolocumab reduces risk of major cardiac events in diabetic patients